Initial chest CT findings in COVID-19: correlation with clinical features

In December 2019, coronavirus disease 2019 (COVID-19), a new de novo infectious disease, was first identified in Wuhan, China and quickly spread across China and around the world. The etiology was a novel betacoronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Lu et al., 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Zhu-jing, Lu, Nan, Gao, Lu-lu, Lv, Jian, Luo, Hua-fu, Jiang, Ji-feng, Xu, Chao, Li, Shi-ya, Mao, Ju-jiang, Li, Kai, Xu, Xiao-pei, Lin, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Zhejiang University Press 2020
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237343/
https://www.ncbi.nlm.nih.gov/pubmed/32748582
http://dx.doi.org/10.1631/jzus.B2000133
Descripción
Sumario:In December 2019, coronavirus disease 2019 (COVID-19), a new de novo infectious disease, was first identified in Wuhan, China and quickly spread across China and around the world. The etiology was a novel betacoronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Lu et al., 2020). On Mar. 11, 2020, World Health Organization (WHO) characterized COVID-19 as a global pandemic. As of Mar. 22, 2020, over 292 000 confirmed COVID-19 cases have been reported globally. To date, COVID-19, with its high infectivity, has killed more people than severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) combined (Wu and McGoogan, 2020).

Ejemplares similares